Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyi Xiang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
ACS Chemical Biology|June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer GrowthThapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoproteinNicholas Veomett, Tao Dao, Hong Liu, et al.
Nature Biotechnology|September 22, 2015
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1Tao Dao, Dmitry Pankov, Andrew Scott, et al.
Blood|December 4, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AMLTao Dao, Guangyan Xiong, Sung Soo Mun, et al.
Nature Biotechnology|August 14, 2018
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoSarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver CancerHong Liu, Yiyang Xu, Jingyi Xiang, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
ACS Chemical Biology|June 16, 2017
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer GrowthThapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoproteinNicholas Veomett, Tao Dao, Hong Liu, et al.
Nature Biotechnology|September 22, 2015
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1Tao Dao, Dmitry Pankov, Andrew Scott, et al.
Blood|December 4, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AMLTao Dao, Guangyan Xiong, Sung Soo Mun, et al.
Nature Biotechnology|August 14, 2018
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoSarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver CancerHong Liu, Yiyang Xu, Jingyi Xiang, et al.
Pageof 2